Peripheral neuropathy Board decisions

The Veteran's bilateral hearing loss is rated as noncompensable, and the Board has remanded this issue.,The Veteran's low back disability (IVDS with spondylosis and degenerative disc disease) warrants a rating of at least 40 percent from July 12, 2012. The evidence is evenly balanced as to whether his symptomatology more nearly approximates flexion to 30 degrees or less.,The Veteran's right lower extremity peripheral neuropathy does not warrant a higher than 20 percent rating.,The Veteran's left lower extremity peripheral neuropathy does not warrant a higher than 10 percent rating.

The Board denied service connection for bilateral peripheral neuropathy of the lower extremities, finding no evidence to support a link between the condition and active service.

The Veteran is seeking higher ratings for his right upper extremity diabetic peripheral neuropathy and earlier effective dates for various benefits.,His claim for a TDIU rating prior to December 27, 2011, and an effective date prior to December 27, 2011, for basic eligibility to DEA benefits under 38 U.S.C. Chapter 35 are also pending.

The Board has reopened the claim for service connection of hyperhidrosis due to new evidence. The rating for residuals of a hematoma of the left scrotum remains denied as there is no voiding or renal dysfunction. The PTSD and depressive disorder NOS are remanded for further evaluation.

The Board has granted service connection for peripheral neuropathy of the right lower extremity. The case is remanded for further development regarding service connection for a respiratory disorder and peripheral neuropathy of the right upper extremity.

The Board denied service connection for the Veteran's claimed disabilities, finding that there was no evidence of a nexus between his current conditions and his military service.,The claims were remanded due to an incomplete medical record regarding the April 2010 surgery.

The Veteran's service-connected conditions did not prevent him from securing and following substantially gainful employment prior to March 18, 2020.

The Board has found that additional development is needed to fully assist the Veteran with his claims, including obtaining relevant medical records and updating VA treatment records. The claims are remanded for these purposes.

The Board has remanded several issues related to service connection for various symptoms, including joint pain, muscle pain, peripheral neuropathy, insomnia, fatigue, memory loss, and weight loss. The appeal is reopened on the basis of new evidence.

The Board has remanded the case due to insufficient medical opinions regarding the cause and aggravation of the Veteran's sleep apnea. The case will be returned for further development.

The Veteran's claims of service connection for kidney cancer, left lower extremity neuropathy secondary to diabetes mellitus II, and right lower extremity neuropathy secondary to diabetes mellitus II have been reopened due to the submission of new and material evidence. The appeal is granted.,The Veteran's PTSD has been rated at 70 percent.

The Board has remanded the claims for service connection due to issues with the Veteran's mailing address and for additional VA examinations.

The Board has dismissed the appeal due to the appellant's withdrawal of all issues currently on appeal.

The Veteran's claims for increased ratings for bilateral lower extremity peripheral neuropathy of the femoral nerves prior to March 30, 2016 have been granted.,An earlier effective date for the award of 20 percent ratings for bilateral lower extremity peripheral neuropathy (femoral nerves) is denied.

The Veteran is seeking compensation under 38 U.S.C. § 1151 for CIDP, a condition he developed as a result of taking VA-prescribed Leflunomide. The Board has determined that further medical examination and opinion are needed to determine if the additional disability was caused by VA's carelessness or negligence.

The Board has remanded the Veteran's claims for HIV and related complications, as well as his claim for dental treatment purposes due to HIV. The AOJ is instructed to verify the exact dates of each period of active duty, inactive duty training, and reserve service that the Veteran attended after May 1987.

The Board has determined that additional development is needed for the Veteran's claims, including a VA examination to assess the current severity of his service-connected diabetic neuropathy and hearing loss/tinnitus. The issues have been remanded.

The Board has granted service connection for right upper, left upper, right lower, and left lower extremity peripheral neuropathy as a result of exposure to herbicides (Agent Orange). The evidence supports the conclusion that these conditions are related to the Veteran's in-service exposure.

The Board has granted service connection for diabetes mellitus, type II and hypertension due to herbicide exposure. Service connection for peripheral neuropathy is remanded as the Veteran's early-onset peripheral neuropathy did not manifest within one year of presumed herbicide exposure.

The Veteran's diabetes mellitus type I is rated at 60 percent since January 16, 2020. The rating is denied as the evidence does not meet the criteria for a higher evaluation.